The estimated Net Worth of Rutul R Shah is at least $243 Tisíc dollars as of 5 April 2024. Mr Shah owns over 117,142 units of Precigen Inc stock worth over $243,098 and over the last 2 years he sold PGEN stock worth over $0.
Mr has made over 7 trades of the Precigen Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 117,142 units of PGEN stock worth $113,628 on 5 April 2024.
The largest trade he's ever made was exercising 117,142 units of Precigen Inc stock on 5 April 2024 worth over $113,628. On average, Mr trades about 24,352 units every 48 days since 2023. As of 5 April 2024 he still owns at least 250,616 units of Precigen Inc stock.
You can see the complete history of Mr Shah stock trades at the bottom of the page.
Rutul R. Shah is the Head of Operations & Portfolio at Precigen Inc.
Over the last 5 years, insiders at Precigen Inc have traded over $44,216,787 worth of Precigen Inc stock and bought 52,689,457 units worth $114,197,137 . The most active insiders traders include Randal J Kirk, Trading S.A. Ares a Helen Sabzevari. On average, Precigen Inc executives and independent directors trade stock every 9 days with the average trade being worth of $358,866. The most recent stock trade was executed by Randal J Kirk on 9 August 2024, trading 23,529,411 units of PGEN stock currently worth $19,999,999.
precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua
Precigen Inc executives and other stock owners filed with the SEC include: